Bafna Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 27, 2026, in which the Board of Directors has inter-alia considered and approved: (i). The appointment of M/s. K. S. Rao & Co., Chartered Accountants, Chennai as the Internal Auditor of the Company for the Financial Year 2026-2027; (ii). The appointment of M/s. N. Sivashankaran & Co., Cost Accountants, Chennai as the Cost Auditor of the Company for the Financial Year 2026-2027
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bafna Pharmaceuticals held a board meeting on March 27, 2026 (from 12:30 PM to 1:00 PM), where the Board approved two key appointments for FY 2026-2027. M/s. K. S. Rao & Co., Chartered Accountants (Chennai), a firm with over 4 decades of experience, was appointed as the Internal Auditor for a one-year term from April 1, 2026 to March 31, 2027. M/s. N. Sivashankaran & Co., Cost Accountants (Chennai), a well-established cost accounting firm, was appointed as the Cost Auditor for the same one-year period. Both appointments are routine regulatory compliance requirements under the Companies Act.
This is a routine annual appointment of statutory auditors with no material impact on shareholders or stock price. It reflects standard corporate governance compliance and does not indicate any concerns about financial reporting.